Role of magnetic resonance Imaging in the management of patients with multiple myeloma: a consensus statement
The IMF’s research division, the International Myeloma Working Group (IMWG), published guidelines in the “Journal of Clinical Oncology” on the use of MRI (magnetic resonance imaging) in myeloma. The IMWG guidelines recommend that all patients with smoldering or asymptomatic myeloma undergo whole-body MRI, or spine and pelvic MRI if whole body MRI is not available. This recommendation is in sync with the IMWG’s new Diagnostic Criteria for myeloma, published in November in theLancet Oncology, in which the presence of more than one MRI lesion is identified as a basis for considering starting full anti-myeloma therapy. The guidelines note that MRI at diagnosis of symptomatic patients (based upon presence of CRAB criteria) provides prognostic information but does not change treatment selection. The IMF’s IMWG is the leader in developing guidelines for the diagnosis, monitoring, and treatment of myeloma.
Authors: Becker p. et al
Click here to view article: